Table 1 Investigation results of the two patients with neuroleptospirosis
Investigation | Case 1 | Case 2 | Reference range |
|---|---|---|---|
Full blood count | |||
 Haemoglobin (mg/dL) | 13.5 | 14 | 13.5–18 |
 White blood cells (× 103/ μL) | 14 | 26 | 4.00–11.00 |
 Neutrophils (× 103/ μL) | 12.51 | 24.41 | 2.0–7.5 |
 Lymphocytes (×103/ μL) | 1.8 | 1.5 | 1.0–4.5 |
 Platelets (×103 /μL) | 329 | 347 | 150–400 |
CRP (mg/dL) | 284 | 14 | < 6 |
Serum creatinine (μmol/L) | 238 | 78.6 | 62–106 |
Urine full report | |||
 Protein | nil | trace | nil |
 Pus cells (/hpf) | nil | 5–6 | nil |
 Red cells (/hpf) | 10–12 | 2–3 | nil |
Liver function tests | |||
 Alanine transaminase (U/L) | 103 | 41.6 | 5–35 |
 Aspartate transaminase (U/L) | 40 | 26.3 | 5–40 |
 Alkaline phosphatase (U/L) | 416 | 102 | 30–120 |
 Gamma-glutamyl transferase (U/L) | 328 | 75 | 0–30 |
 Total bilirubin (μmol/L) | 17.2 | 10.6 | 5–17 |
Cerebrospinal fluid analysis | |||
 White blood cells (/μL) | 166 | 64.7 | 0–5 |
 Polymorphonuclear cells (%) | 96 | 13 | 0 |
 Mononuclear cells (%) | 3.9 | 87 | 60–70% |
 Protein (mg/dL) | 52.4 | 39 | 22–38 |
 Glucose (mg/dL) | 83.6 | 72.9 | 60–80% of random blood glucose |
Random blood glucose (mg/dL) | 126 | 110 | 120–140 |